HK Stock MarketDetailed Quotes

06990 SKB BIO-B

Watchlist
  • 182.900
  • +4.700+2.64%
Market Closed Sep 13 16:08 CST
40.76BMarket Cap-159737P/E (TTM)

SKB BIO-B Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
32.17%1.38B
91.62%1.54B
--1.05B
2,387.26%803.93M
2,266.02%623.99M
--32.32M
--26.37M
Operating income
32.17%1.38B
91.62%1.54B
1.05B
2,387.26%803.93M
2,266.02%623.99M
32.32M
26.37M
Cost of sales
17.40%-306.1M
-182.24%-781.31M
---370.57M
-1,248.74%-276.83M
-991.51%-182.76M
---20.53M
---16.74M
Operating expenses
17.40%-306.1M
-182.24%-781.31M
-370.57M
-1,248.74%-276.83M
-991.51%-182.76M
-20.53M
-16.74M
Gross profit
59.35%1.08B
44.03%759.19M
675.66M
4,368.13%527.11M
4,482.29%441.23M
11.8M
9.63M
Selling expenses
---41.15M
---19.53M
----
----
----
----
----
Administrative expenses
26.37%-65.84M
-90.84%-181.88M
---89.42M
0.91%-95.3M
17.88%-63.59M
---96.17M
---77.44M
Research and development expenses
-33.04%-652.34M
-21.87%-1.03B
---490.35M
-16.26%-845.98M
3.58%-513.62M
---727.67M
---532.68M
Special items of operating profit
291.36%94.4M
2,156.07%89.81M
--24.12M
-112.54%-4.37M
-228.96%-28.09M
--34.84M
--21.78M
Operating profit
243.11%411.76M
8.40%-383.38M
120.01M
46.15%-418.55M
71.65%-164.08M
-777.2M
-578.7M
Financing cost
96.82%-2.51M
43.35%-84.31M
---78.73M
-32.17%-148.81M
-38.98%-110.43M
---112.59M
---79.46M
Earning before tax
891.47%409.25M
17.57%-467.69M
41.28M
36.24%-567.36M
58.29%-274.51M
-889.8M
-658.16M
Tax
-36.76%-99.03M
-118.41%-106.44M
---72.41M
---48.74M
---46.72M
----
----
After-tax profit from continuing operations
1,096.55%310.23M
6.81%-574.13M
-31.13M
30.76%-616.1M
51.19%-321.23M
-889.8M
-658.16M
Earning after tax
1,096.55%310.23M
6.81%-574.13M
-31.13M
30.76%-616.1M
51.19%-321.23M
-889.8M
-658.16M
Profit attributable to shareholders
1,096.55%310.23M
6.81%-574.13M
-31.13M
30.76%-616.1M
51.19%-321.23M
-889.8M
-658.16M
Basic earnings per share
929.41%1.41
50.52%-2.84
-0.17
35.51%-5.74
55.70%-2.99
-8.9
-6.75
Diluted earnings per share
929.41%1.41
50.52%-2.84
-0.17
35.51%-5.74
55.70%-2.99
-8.9
-6.75
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
IAS
HKAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
KPMG
--
KPMG
--
KPMG
--
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover 32.17%1.38B91.62%1.54B--1.05B2,387.26%803.93M2,266.02%623.99M--32.32M--26.37M
Operating income 32.17%1.38B91.62%1.54B1.05B2,387.26%803.93M2,266.02%623.99M32.32M26.37M
Cost of sales 17.40%-306.1M-182.24%-781.31M---370.57M-1,248.74%-276.83M-991.51%-182.76M---20.53M---16.74M
Operating expenses 17.40%-306.1M-182.24%-781.31M-370.57M-1,248.74%-276.83M-991.51%-182.76M-20.53M-16.74M
Gross profit 59.35%1.08B44.03%759.19M675.66M4,368.13%527.11M4,482.29%441.23M11.8M9.63M
Selling expenses ---41.15M---19.53M--------------------
Administrative expenses 26.37%-65.84M-90.84%-181.88M---89.42M0.91%-95.3M17.88%-63.59M---96.17M---77.44M
Research and development expenses -33.04%-652.34M-21.87%-1.03B---490.35M-16.26%-845.98M3.58%-513.62M---727.67M---532.68M
Special items of operating profit 291.36%94.4M2,156.07%89.81M--24.12M-112.54%-4.37M-228.96%-28.09M--34.84M--21.78M
Operating profit 243.11%411.76M8.40%-383.38M120.01M46.15%-418.55M71.65%-164.08M-777.2M-578.7M
Financing cost 96.82%-2.51M43.35%-84.31M---78.73M-32.17%-148.81M-38.98%-110.43M---112.59M---79.46M
Earning before tax 891.47%409.25M17.57%-467.69M41.28M36.24%-567.36M58.29%-274.51M-889.8M-658.16M
Tax -36.76%-99.03M-118.41%-106.44M---72.41M---48.74M---46.72M--------
After-tax profit from continuing operations 1,096.55%310.23M6.81%-574.13M-31.13M30.76%-616.1M51.19%-321.23M-889.8M-658.16M
Earning after tax 1,096.55%310.23M6.81%-574.13M-31.13M30.76%-616.1M51.19%-321.23M-889.8M-658.16M
Profit attributable to shareholders 1,096.55%310.23M6.81%-574.13M-31.13M30.76%-616.1M51.19%-321.23M-889.8M-658.16M
Basic earnings per share 929.41%1.4150.52%-2.84-0.1735.51%-5.7455.70%-2.99-8.9-6.75
Diluted earnings per share 929.41%1.4150.52%-2.84-0.1735.51%-5.7455.70%-2.99-8.9-6.75
Currency Unit CNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASIASHKASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor --KPMG--KPMG--KPMG--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data